speb/financial-data huggingface dataset:
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 616374207.72
JCARE.SW income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1168976.03
JCARE.SW income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 60993891.06
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Other Payable: 3746978882.28
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Other Properties: 1036149463.93
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1706237013.92
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 490624181.31
JCARE.SW income_statement (quarterly, 2025-06-30) — Other Special Charges: 63593.95
JCARE.SW income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Payables: 6323813100.64
JCARE.SW cash_flow (quarterly, 2025-06-30) — Paymentson Behalfof Employees: -524862719.00
JCARE.SW cash_flow (quarterly, 2025-06-30) — Paymentsto Suppliersfor Goodsand Services: -1137781234.15
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 256617690.36
JCARE.SW income_statement (quarterly, 2025-06-30) — Pretax Income: 921623472.77
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Properties: 4874405183.17
JCARE.SW cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -3250665470.92
JCARE.SW cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -301175403.98
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Raw Materials: 593382897.04
JCARE.SW cash_flow (quarterly, 2025-06-30) — Receiptsfrom Customers: 4136016372.56
JCARE.SW income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1426716545.69
JCARE.SW cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1497781809.00
JCARE.SW income_statement (quarterly, 2025-06-30) — Research And Development: 310795711.08
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 10907386718.31
JCARE.SW cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 3147861922.87
JCARE.SW cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 30028985.00
JCARE.SW income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 711012544.97
JCARE.SW income_statement (quarterly, 2025-06-30) — Selling General And Administration: 585932664.48
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Share Issued: 1829453386.00
JCARE.SW income_statement (quarterly, 2025-06-30) — Special Income Charges: -7674021.08
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 14645400560.24
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 12821691721.86
JCARE.SW income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -3244546.15
JCARE.SW income_statement (quarterly, 2025-06-30) — Tax Provision: 119032446.87
JCARE.SW income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.13
JCARE.SW cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid Direct: -441853244.88
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Total Assets: 35552215282.00
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 16930964049.26
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Total Debt: 4975972517.11
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 23536614709.87
JCARE.SW income_statement (quarterly, 2025-06-30) — Total Expenses: 3022893140.77
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 12015600572.13
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 12161337249.78
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2918049807.43
JCARE.SW income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 929492469.09
JCARE.SW income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 1080632.44
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 279656691.03
JCARE.SW income_statement (quarterly, 2025-06-30) — Total Unusual Items: -25121300.67
JCARE.SW income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -25121300.67
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Work In Process: 760775827.59
JCARE.SW balance_sheet (quarterly, 2025-06-30) — Working Capital: 14293327267.52
JCARE.SW income_statement (quarterly, 2025-06-30) — Write Off: -847662.66
JCARE.SW income_statement (annual, 2025-12-31) — +Operating Expense: 6315394921.16
JCARE.SW income_statement (quarterly, 2025-12-31) — +Operating Expense: 1663791432.26
JCARE.SW income_statement (annual, 2025-12-31) — +Total Revenue: 15215738549.28
JCARE.SW income_statement (quarterly, 2025-12-31) — +Total Revenue: 3737931599.66
JCARE.SW balance_sheet (annual, 2025-12-31) — Accounts Payable: 1987309812.53
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1987309812.53
JCARE.SW balance_sheet (annual, 2025-12-31) — Accounts Receivable: 2722328581.17
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 2722328581.17
JCARE.SW balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -7355660410.51
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -7355660410.51
JCARE.SW balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 663248499.95
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 663248499.95
JCARE.SW balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -77633735.84
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -77633735.84
JCARE.SW cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 107841493.53
JCARE.SW balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 990428693.50
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 990428693.50
JCARE.SW income_statement (annual, 2025-12-31) — Basic Average Shares: 182951744.00
JCARE.SW income_statement (annual, 2025-12-31) — Basic EPS: 7.30
JCARE.SW cash_flow (annual, 2025-12-31) — Beginning Cash Position: 14842645678.32
JCARE.SW cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 14507137859.82
JCARE.SW cash_flow (annual, 2025-12-31) — Capital Expenditure: -767197834.66
JCARE.SW cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -123075687.55
JCARE.SW balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 21905133.24
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 21905133.24
JCARE.SW balance_sheet (annual, 2025-12-31) — Capital Stock: 1829453386.00
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1829453386.00
JCARE.SW balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 13610715754.64
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 13610715754.64
JCARE.SW balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 15304818521.33
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 15304818521.33
JCARE.SW cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -447069886.18
JCARE.SW cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -23967504.79
JCARE.SW balance_sheet (annual, 2025-12-31) — Cash Equivalents: 114879136.27
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 114879136.27
JCARE.SW balance_sheet (annual, 2025-12-31) — Cash Financial: 13495836618.37
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Cash Financial: 13495836618.37
JCARE.SW cash_flow (annual, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: 3891842483.63
JCARE.SW cash_flow (quarterly, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: 890440511.56
JCARE.SW cash_flow (annual, 2025-12-31) — Change In Inventory: 357422232.29
JCARE.SW cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -138941574.07
JCARE.SW cash_flow (annual, 2025-12-31) — Change In Payable: -282135804.72
JCARE.SW cash_flow (annual, 2025-12-31) — Change In Receivables: -39573466.62
JCARE.SW cash_flow (annual, 2025-12-31) — Change In Working Capital: -103228613.12
JCARE.SW cash_flow (annual, 2025-12-31) — Changes In Cash: -2923273187.64
JCARE.SW cash_flow (quarterly, 2025-12-31) — Changes In Cash: -2685351102.28
JCARE.SW cash_flow (annual, 2025-12-31) — Classesof Cash Payments: -11539762905.30
JCARE.SW cash_flow (quarterly, 2025-12-31) — Classesof Cash Payments: -2854936048.24
JCARE.SW cash_flow (annual, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: 17101344995.25
JCARE.SW cash_flow (quarterly, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: 4227068153.72
JCARE.SW balance_sheet (annual, 2025-12-31) — Common Stock: 1829453386.00
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Common Stock: 1829453386.00
JCARE.SW balance_sheet (annual, 2025-12-31) — Common Stock Equity: 15179567286.42
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 15179567286.42
JCARE.SW balance_sheet (annual, 2025-12-31) — Construction In Progress: 615348388.91
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 615348388.91
JCARE.SW income_statement (annual, 2025-12-31) — Cost Of Revenue: 5714323041.92
JCARE.SW income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1459374631.24
JCARE.SW balance_sheet (annual, 2025-12-31) — Current Assets: 23160168339.65
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Current Assets: 23160168339.65
JCARE.SW balance_sheet (annual, 2025-12-31) — Current Debt: 2240000000.00
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Current Debt: 2240000000.00
JCARE.SW balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 2613229691.10
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 2613229691.10
JCARE.SW balance_sheet (annual, 2025-12-31) — Current Liabilities: 8855914927.12
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 8855914927.12
JCARE.SW cash_flow (annual, 2025-12-31) — Depreciation: 709980094.06
JCARE.SW cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 817821587.59
JCARE.SW income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 107345958.33
JCARE.SW income_statement (annual, 2025-12-31) — Depreciation Income Statement: 107345958.33
JCARE.SW income_statement (annual, 2025-12-31) — Diluted Average Shares: 182951744.00
JCARE.SW income_statement (annual, 2025-12-31) — Diluted EPS: 7.30
JCARE.SW balance_sheet (annual, 2025-12-31) — Dividends Payable: 14017248.88
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 14017248.88
JCARE.SW income_statement (annual, 2025-12-31) — EBIT: 3453356187.64
JCARE.SW income_statement (quarterly, 2025-12-31) — EBIT: 533801558.78
JCARE.SW income_statement (annual, 2025-12-31) — EBITDA: 4271177775.23
JCARE.SW income_statement (quarterly, 2025-12-31) — EBITDA: 533801558.78
JCARE.SW cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -173677395.73
JCARE.SW cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -76091662.59
JCARE.SW cash_flow (annual, 2025-12-31) — End Cash Position: 11745695094.95
JCARE.SW cash_flow (quarterly, 2025-12-31) — End Cash Position: 11745695094.95
JCARE.SW cash_flow (annual, 2025-12-31) — Financing Cash Flow: -2946364487.55
JCARE.SW cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -1060459441.12
JCARE.SW balance_sheet (annual, 2025-12-31) — Finished Goods: 870746403.26
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Finished Goods: 870746403.26
JCARE.SW cash_flow (annual, 2025-12-31) — Free Cash Flow: 3124644648.97
JCARE.SW cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 767364824.01
JCARE.SW cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -90986091.47
JCARE.SW cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 4070855.53
JCARE.SW income_statement (annual, 2025-12-31) — General And Administrative Expense: 218864029.98
JCARE.SW income_statement (quarterly, 2025-12-31) — General And Administrative Expense: -446033568.26
JCARE.SW balance_sheet (annual, 2025-12-31) — Goodwill: 636339503.82
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Goodwill: 636339503.82
JCARE.SW balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 1886912700.31
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1886912700.31
JCARE.SW balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 2799962317.01
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 2799962317.01
JCARE.SW balance_sheet (annual, 2025-12-31) — Gross PPE: 13436409051.97
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Gross PPE: 13436409051.97
JCARE.SW income_statement (annual, 2025-12-31) — Gross Profit: 9501415507.36
JCARE.SW income_statement (quarterly, 2025-12-31) — Gross Profit: 2278556968.42
JCARE.SW income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 120789538.71
JCARE.SW income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 99904168.28
JCARE.SW income_statement (annual, 2025-12-31) — Interest Expense: 87048116.17
JCARE.SW income_statement (quarterly, 2025-12-31) — Interest Expense: 20229126.02
JCARE.SW income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 87048116.17
JCARE.SW income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 20229126.02
JCARE.SW income_statement (annual, 2025-12-31) — Interest Income: 469337871.02
JCARE.SW income_statement (quarterly, 2025-12-31) — Interest Income: 104989997.31
JCARE.SW income_statement (annual, 2025-12-31) — Interest Income Non Operating: 469337871.02
JCARE.SW income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 104989997.31
JCARE.SW balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: 0.00
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: 0.00
JCARE.SW balance_sheet (annual, 2025-12-31) — Inventory: 2213802715.08
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Inventory: 2213802715.08
JCARE.SW balance_sheet (annual, 2025-12-31) — Invested Capital: 18991833885.46
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Invested Capital: 18991833885.46
JCARE.SW cash_flow (annual, 2025-12-31) — Investing Cash Flow: -3868751183.72
JCARE.SW cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -2515332172.72
JCARE.SW balance_sheet (annual, 2025-12-31) — Investment Properties: 15276446.14
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Investment Properties: 15276446.14
JCARE.SW balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 990428693.50
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 990428693.50
JCARE.SW cash_flow (annual, 2025-12-31) — Issuance Of Debt: 4181771400.01
JCARE.SW cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 1059996555.56
JCARE.SW balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 21905133.24
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 21905133.24
JCARE.SW balance_sheet (annual, 2025-12-31) — Long Term Debt: 1572266599.04
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1572266599.04
JCARE.SW balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1594171732.28
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1594171732.28
JCARE.SW cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 4181771400.01
JCARE.SW cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 1059996555.56
JCARE.SW cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -5273350637.73
JCARE.SW cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -2045887428.73
JCARE.SW balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 1483192139.93
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 1483192139.93
JCARE.SW balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 6870656278.78
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 6870656278.78
JCARE.SW balance_sheet (annual, 2025-12-31) — Minority Interest: 9188581036.62
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Minority Interest: 9188581036.62
JCARE.SW income_statement (annual, 2025-12-31) — Minority Interests: -1529481146.75
JCARE.SW income_statement (quarterly, 2025-12-31) — Minority Interests: -176133782.97
JCARE.SW income_statement (annual, 2025-12-31) — Net Income: 1335547730.75
JCARE.SW income_statement (quarterly, 2025-12-31) — Net Income: 244333599.47
JCARE.SW income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1335547730.75
JCARE.SW income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 244333599.47
JCARE.SW income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 2865028877.50
JCARE.SW income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 420467382.44
JCARE.SW income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1335547730.75
JCARE.SW income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 244333599.47
JCARE.SW income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1335547730.75
JCARE.SW income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 244333599.47
JCARE.SW cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 2865028877.50
JCARE.SW income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 2865028877.50
JCARE.SW income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 420467382.44
JCARE.SW income_statement (annual, 2025-12-31) — Net Interest Income: 375464358.68
JCARE.SW income_statement (quarterly, 2025-12-31) — Net Interest Income: 112730225.12
JCARE.SW cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -1294737190.14
JCARE.SW cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -559285118.01
JCARE.SW cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -1091579237.72
JCARE.SW cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -985890873.17
JCARE.SW cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -1091579237.72
JCARE.SW cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -985890873.17
JCARE.SW income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 375464358.68
JCARE.SW income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 112730225.12
JCARE.SW cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -771540961.68
JCARE.SW cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -41138350.60
JCARE.SW cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1861935039.75
JCARE.SW cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -1857408058.49
JCARE.SW balance_sheet (annual, 2025-12-31) — Net PPE: 6080748641.46
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Net PPE: 6080748641.46
JCARE.SW cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -712078953.83
JCARE.SW cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -98638996.22
JCARE.SW balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 13292654586.11
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 13292654586.11
JCARE.SW balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 314844828.54
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 314844828.54
JCARE.SW balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 327844468.42
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 327844468.42
JCARE.SW balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 822667725.40
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 822667725.40
JCARE.SW balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 268219857.78
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 268219857.78
JCARE.SW income_statement (annual, 2025-12-31) — Normalized EBITDA: 4380099235.77
JCARE.SW income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 614778823.57
JCARE.SW income_statement (annual, 2025-12-31) — Normalized Income: 1428249623.51
JCARE.SW income_statement (quarterly, 2025-12-31) — Normalized Income: 310630574.14
JCARE.SW cash_flow (annual, 2025-12-31) — Operating Cash Flow: 3891842483.63
JCARE.SW income_statement (annual, 2025-12-31) — Operating Income: 3186020586.20
JCARE.SW income_statement (quarterly, 2025-12-31) — Operating Income: 614765536.16
JCARE.SW income_statement (annual, 2025-12-31) — Operating Revenue: 15215738549.28
JCARE.SW income_statement (quarterly, 2025-12-31) — Operating Revenue: 3737931599.66
JCARE.SW balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1829453386.00
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1829453386.00
JCARE.SW cash_flow (annual, 2025-12-31) — Other Cash Paymentsfrom Operating Activities: -4562982019.70
JCARE.SW cash_flow (quarterly, 2025-12-31) — Other Cash Paymentsfrom Operating Activities: -1198195109.14
JCARE.SW cash_flow (annual, 2025-12-31) — Other Cash Receiptsfrom Operating Activities: 652103130.06
JCARE.SW cash_flow (quarterly, 2025-12-31) — Other Cash Receiptsfrom Operating Activities: 169305913.48
JCARE.SW balance_sheet (annual, 2025-12-31) — Other Current Assets: 1010462562.60
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1010462562.60
JCARE.SW balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 7996328.84
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 7996328.84
JCARE.SW balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 1250573196.49
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1250573196.49
JCARE.SW balance_sheet (annual, 2025-12-31) — Other Inventories: 109469320.93
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Other Inventories: 109469320.93
JCARE.SW cash_flow (annual, 2025-12-31) — Other Non Cash Items: 276301836.41
JCARE.SW balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 660059793.71
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 660059793.71
JCARE.SW income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -91066875.56
JCARE.SW income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -72930646.38
JCARE.SW income_statement (annual, 2025-12-31) — Other Operating Expenses: 215253105.38
JCARE.SW income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 72496911.36
JCARE.SW balance_sheet (annual, 2025-12-31) — Other Payable: 3870569617.91
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Other Payable: 3870569617.91
JCARE.SW balance_sheet (annual, 2025-12-31) — Other Properties: 1049257582.07
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Other Properties: 1049257582.07
JCARE.SW balance_sheet (annual, 2025-12-31) — Other Receivables: 1705791069.31
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1705791069.31
JCARE.SW balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 1694102766.69
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 1694102766.69
JCARE.SW income_statement (annual, 2025-12-31) — Other Special Charges: -2972859.03
JCARE.SW income_statement (quarterly, 2025-12-31) — Other Special Charges: -3288388.34
JCARE.SW income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
JCARE.SW income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
JCARE.SW balance_sheet (annual, 2025-12-31) — Payables: 6112633686.79
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Payables: 6112633686.79
JCARE.SW cash_flow (annual, 2025-12-31) — Paymentson Behalfof Employees: -2502889720.67
JCARE.SW cash_flow (quarterly, 2025-12-31) — Paymentson Behalfof Employees: -528845548.27
JCARE.SW cash_flow (annual, 2025-12-31) — Paymentsto Suppliersfor Goodsand Services: -4473891164.93
JCARE.SW cash_flow (quarterly, 2025-12-31) — Paymentsto Suppliersfor Goodsand Services: -1127895390.83
JCARE.SW balance_sheet (annual, 2025-12-31) — Prepaid Assets: 202964890.16
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 202964890.16
JCARE.SW income_statement (annual, 2025-12-31) — Pretax Income: 3366308071.47
JCARE.SW income_statement (quarterly, 2025-12-31) — Pretax Income: 513572432.76
JCARE.SW balance_sheet (annual, 2025-12-31) — Properties: 4901146802.21
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Properties: 4901146802.21
JCARE.SW cash_flow (annual, 2025-12-31) — Purchase Of Investment: -11235362279.51
JCARE.SW cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -3934706170.08
JCARE.SW cash_flow (annual, 2025-12-31) — Purchase Of PPE: -767197834.66
JCARE.SW cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -123075687.55
JCARE.SW balance_sheet (annual, 2025-12-31) — Raw Materials: 528379146.37
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Raw Materials: 528379146.37
JCARE.SW cash_flow (annual, 2025-12-31) — Receiptsfrom Customers: 16449241865.19
JCARE.SW cash_flow (quarterly, 2025-12-31) — Receiptsfrom Customers: 4057762240.24
JCARE.SW income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 5714323041.92
JCARE.SW income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1459374631.24
JCARE.SW income_statement (annual, 2025-12-31) — Reconciled Depreciation: 817821587.59
JCARE.SW cash_flow (annual, 2025-12-31) — Repayment Of Debt: -5273350637.73
JCARE.SW cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -2045887428.73
JCARE.SW income_statement (annual, 2025-12-31) — Research And Development: 1273012436.33
JCARE.SW income_statement (quarterly, 2025-12-31) — Research And Development: 341996663.24
JCARE.SW balance_sheet (annual, 2025-12-31) — Retained Earnings: 11402453599.97
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 11402453599.97
JCARE.SW cash_flow (annual, 2025-12-31) — Sale Of Investment: 9940625089.37
JCARE.SW cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 3375421052.07
JCARE.SW cash_flow (annual, 2025-12-31) — Sale Of PPE: 55118880.83
JCARE.SW cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 24436691.33
JCARE.SW income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 3527671953.06
JCARE.SW income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 494597603.83
JCARE.SW income_statement (annual, 2025-12-31) — Selling General And Administration: 3746535983.04
JCARE.SW income_statement (quarterly, 2025-12-31) — Selling General And Administration: 48564035.57
JCARE.SW balance_sheet (annual, 2025-12-31) — Share Issued: 1829453386.00
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Share Issued: 1829453386.00
JCARE.SW income_statement (annual, 2025-12-31) — Special Income Charges: -119861172.16
JCARE.SW income_statement (quarterly, 2025-12-31) — Special Income Charges: -88586033.27
JCARE.SW balance_sheet (annual, 2025-12-31) — Stockholders Equity: 15179567286.42
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 15179567286.42
JCARE.SW balance_sheet (annual, 2025-12-31) — Tangible Book Value: 13292654586.11
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 13292654586.11
JCARE.SW income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -16219567.78
JCARE.SW income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -14680290.12
JCARE.SW income_statement (annual, 2025-12-31) — Tax Provision: 501279193.97
JCARE.SW income_statement (quarterly, 2025-12-31) — Tax Provision: 93105050.32
JCARE.SW income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
JCARE.SW income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.18
JCARE.SW cash_flow (annual, 2025-12-31) — Taxes Refund Paid Direct: -1669739606.32
JCARE.SW cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid Direct: -481691593.92
JCARE.SW balance_sheet (annual, 2025-12-31) — Total Assets: 35414299308.64
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Total Assets: 35414299308.64
JCARE.SW balance_sheet (annual, 2025-12-31) — Total Capitalization: 16751833885.46
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 16751833885.46
JCARE.SW balance_sheet (annual, 2025-12-31) — Total Debt: 4207401423.38
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Total Debt: 4207401423.38
JCARE.SW balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 24368148323.04
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 24368148323.04
JCARE.SW income_statement (annual, 2025-12-31) — Total Expenses: 12029717963.08
JCARE.SW income_statement (quarterly, 2025-12-31) — Total Expenses: 3123166063.50
JCARE.SW balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 11046150985.60
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 11046150985.60
JCARE.SW balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 12254130968.99
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 12254130968.99
JCARE.SW balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2190236058.48
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2190236058.48
JCARE.SW income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 3465928984.17
JCARE.SW income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 595057116.28
JCARE.SW income_statement (annual, 2025-12-31) — Total Other Finance Cost: 6825396.17
JCARE.SW income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: -27969353.83
JCARE.SW balance_sheet (annual, 2025-12-31) — Total Tax Payable: 240737007.47
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 240737007.47
JCARE.SW income_statement (annual, 2025-12-31) — Total Unusual Items: -108921460.54
JCARE.SW income_statement (quarterly, 2025-12-31) — Total Unusual Items: -80977264.79
JCARE.SW income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -108921460.54
JCARE.SW income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -80977264.79
JCARE.SW balance_sheet (annual, 2025-12-31) — Work In Process: 705207844.52
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Work In Process: 705207844.52
JCARE.SW balance_sheet (annual, 2025-12-31) — Working Capital: 14304253412.53
JCARE.SW balance_sheet (quarterly, 2025-12-31) — Working Capital: 14304253412.53
JCARE.SW income_statement (annual, 2025-12-31) — Write Off: 2044492.48
JCARE.SW income_statement (quarterly, 2025-12-31) — Write Off: -8029746.67
JCARE.SW income_statement (quarterly, 2026-03-31) — +Operating Expense: 1356670290.97
JCARE.SW income_statement (quarterly, 2026-03-31) — +Total Revenue: 3721497528.96
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1881439910.01
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2769059544.58
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 2323327871.47
JCARE.SW income_statement (quarterly, 2026-03-31) — Basic Average Shares: 180422271.00
JCARE.SW income_statement (quarterly, 2026-03-31) — Basic EPS: 2.30
JCARE.SW cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 11745695094.95
JCARE.SW cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -171793795.95
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 21780660.17
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1829453386.00
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 12868686284.47
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 13914316879.98
JCARE.SW cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -15720474.02
JCARE.SW cash_flow (quarterly, 2026-03-31) — Cash Flowsfromusedin Operating Activities Direct: 914648142.82
JCARE.SW cash_flow (quarterly, 2026-03-31) — Changes In Cash: -745676092.36
JCARE.SW cash_flow (quarterly, 2026-03-31) — Classesof Cash Payments: -2922350150.40
JCARE.SW cash_flow (quarterly, 2026-03-31) — Classesof Cash Receiptsfrom Operating Activities: 4162819747.44
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Common Stock: 1829453386.00
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 15610934233.56
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 664273287.83
JCARE.SW income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1369914508.98
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Current Assets: 22150504063.17
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Current Debt: 2817316268.37
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2903440726.98
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 9355984477.78
JCARE.SW income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 180422271.00
JCARE.SW income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.30
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 351946018.88
JCARE.SW income_statement (quarterly, 2026-03-31) — EBIT: 1052336268.67
JCARE.SW income_statement (quarterly, 2026-03-31) — EBITDA: 1052336268.67
JCARE.SW cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -99036350.12
JCARE.SW cash_flow (quarterly, 2026-03-31) — End Cash Position: 10900982652.47
JCARE.SW cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -646157640.65
JCARE.SW cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 742854346.87
JCARE.SW income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 202193332.67
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Goodwill: 636339503.82
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1868792956.20
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Gross PPE: 6036258869.39
JCARE.SW income_statement (quarterly, 2026-03-31) — Gross Profit: 2351583019.98
JCARE.SW income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 721485.11
JCARE.SW income_statement (quarterly, 2026-03-31) — Interest Expense: 15498377.11
JCARE.SW income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 15498377.11
JCARE.SW income_statement (quarterly, 2026-03-31) — Interest Income: 64901627.44
JCARE.SW income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 64901627.44
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Inventory: 2126886598.33
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Invested Capital: 19409175124.78
JCARE.SW cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1014166594.53
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Investment Properties: 15066225.28
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 2323327871.47
JCARE.SW cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 1776432252.90
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 21780660.17
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 980924622.85
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1002705283.02
JCARE.SW cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 1776432252.90
JCARE.SW cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -2079462186.24
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 1478200827.63
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Minority Interest: 8918649578.62
JCARE.SW income_statement (quarterly, 2026-03-31) — Minority Interests: -468479478.57
JCARE.SW cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 51450000.00
JCARE.SW income_statement (quarterly, 2026-03-31) — Net Income: 414971222.32
JCARE.SW income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 414971222.32
JCARE.SW income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 883450700.89
JCARE.SW income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 414971222.32
JCARE.SW income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 414971222.32
JCARE.SW income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 883450700.89
JCARE.SW income_statement (quarterly, 2026-03-31) — Net Interest Income: 14210786.86
JCARE.SW cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -896756685.23
JCARE.SW cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -303029933.34
JCARE.SW cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -303029933.34
JCARE.SW income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 14210786.86
JCARE.SW cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 4563996.71
JCARE.SW cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -2246769.44
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Net PPE: 6036258869.39
JCARE.SW cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -166613139.86
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 13742141277.36
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 316265661.41
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 320480802.61
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 810554668.00
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 268544369.24
JCARE.SW income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1070120910.48
JCARE.SW income_statement (quarterly, 2026-03-31) — Normalized Income: 430124848.94
JCARE.SW income_statement (quarterly, 2026-03-31) — Operating Income: 994912729.01
JCARE.SW income_statement (quarterly, 2026-03-31) — Operating Revenue: 3721497528.96
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1829453386.00
JCARE.SW cash_flow (quarterly, 2026-03-31) — Other Cash Paymentsfrom Operating Activities: -913587428.07
JCARE.SW cash_flow (quarterly, 2026-03-31) — Other Cash Receiptsfrom Operating Activities: 101003415.88
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1541469032.93
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 5896788.45
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1232453452.38
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 478327602.28
JCARE.SW income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -3531732.49
JCARE.SW income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 47429371.86
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Other Payable: 3822796988.55
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Other Properties: 5371985581.56
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1560756781.61
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 1045630595.51
JCARE.SW income_statement (quarterly, 2026-03-31) — Other Special Charges: 64051.92
JCARE.SW income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Payables: 6340229768.21
JCARE.SW cash_flow (quarterly, 2026-03-31) — Paymentson Behalfof Employees: -914021168.65
JCARE.SW cash_flow (quarterly, 2026-03-31) — Paymentsto Suppliersfor Goodsand Services: -1094741553.68
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 238015225.74
JCARE.SW income_statement (quarterly, 2026-03-31) — Pretax Income: 1036837891.56
JCARE.SW cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -4533897230.45
JCARE.SW cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -171793795.95
JCARE.SW cash_flow (quarterly, 2026-03-31) — Receiptsfrom Customers: 4061816331.56
JCARE.SW income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1369914508.98
JCARE.SW cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -2079462186.24
JCARE.SW income_statement (quarterly, 2026-03-31) — Research And Development: 233701640.02
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 11817424822.29
JCARE.SW cash_flow (quarterly, 2026-03-31) — Sale Of Business: 51450000.00
JCARE.SW cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 3637140545.22
JCARE.SW cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 5180656.09
JCARE.SW income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 896557271.61
JCARE.SW income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1098750604.28
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Share Issued: 1829453386.00
JCARE.SW income_statement (quarterly, 2026-03-31) — Special Income Charges: -126479.48
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 15610934233.56
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 13742141277.36
JCARE.SW income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -2631015.19
JCARE.SW income_statement (quarterly, 2026-03-31) — Tax Provision: 153387190.67
JCARE.SW income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.15
JCARE.SW cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid Direct: -325821454.22
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Total Assets: 35477298744.83
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 16591858856.41
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Total Debt: 3906146010.00
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 24529583812.18
JCARE.SW income_statement (quarterly, 2026-03-31) — Total Expenses: 2726584799.95
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 10947714932.65
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 13326794681.66
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1591730454.87
JCARE.SW income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 1040369624.05
JCARE.SW income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 35192463.47
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 284046850.77
JCARE.SW income_statement (quarterly, 2026-03-31) — Total Unusual Items: -17784641.81
JCARE.SW income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -17784641.81
JCARE.SW balance_sheet (quarterly, 2026-03-31) — Working Capital: 12794519585.39
JCARE.SW income_statement (quarterly, 2026-03-31) — Write Off: -659057.55
JCE income_statement (annual, 2021-12-31) — Basic Average Shares: 16011571.00
JCE income_statement (annual, 2021-12-31) — Basic EPS: 3.96
JCE income_statement (annual, 2021-12-31) — Diluted Average Shares: 16011571.00
JCE income_statement (annual, 2021-12-31) — Diluted EPS: 3.96
JCE income_statement (annual, 2021-12-31) — Other Operating Expenses: 4116.00
JCE income_statement (annual, 2022-12-31) — +Operating Expense: 208433.00
JCE income_statement (annual, 2022-12-31) — +Total Revenue: -47220928.00
JCE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 187612349.00
JCE balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 352120.00
JCE income_statement (annual, 2022-12-31) — Basic Average Shares: 16023433.00
JCE income_statement (annual, 2022-12-31) — Basic EPS: -2.96
JCE balance_sheet (annual, 2022-12-31) — Capital Stock: 160726.00
JCE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 6847.00
JCE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 380213.00
JCE balance_sheet (annual, 2022-12-31) — Cash Financial: 6847.00
JCE balance_sheet (annual, 2022-12-31) — Common Stock: 160726.00
JCE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 193568292.00
JCE balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 84988.00
JCE income_statement (annual, 2022-12-31) — Diluted Average Shares: 16023433.00
JCE income_statement (annual, 2022-12-31) — Diluted EPS: -2.96
JCE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -47429361.00
JCE balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 193340897.00
JCE income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -1637397.00
JCE income_statement (annual, 2022-12-31) — General And Administrative Expense: 208234.00
JCE income_statement (annual, 2022-12-31) — Interest Expense: 0.00
JCE income_statement (annual, 2022-12-31) — Interest Income: 4391.00
JCE balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 193693017.00
JCE balance_sheet (annual, 2022-12-31) — Investments And Advances: 193693017.00
JCE income_statement (annual, 2022-12-31) — Net Income: -47429361.00
JCE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -47429361.00
JCE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -47429361.00
JCE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -47429361.00
JCE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -47429361.00
JCE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -47429361.00
JCE income_statement (annual, 2022-12-31) — Net Interest Income: 4391.00
JCE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 193568292.00
JCE income_statement (annual, 2022-12-31) — Normalized Income: -47429361.00
JCE income_statement (annual, 2022-12-31) — Operating Revenue: -47220928.00
JCE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 16072627.00
JCE income_statement (annual, 2022-12-31) — Other Operating Expenses: 199.00
JCE balance_sheet (annual, 2022-12-31) — Other Payable: 607566.00
JCE balance_sheet (annual, 2022-12-31) — Payables: 607566.00
JCE income_statement (annual, 2022-12-31) — Pretax Income: -47429361.00
JCE balance_sheet (annual, 2022-12-31) — Receivables: 431386.00
JCE balance_sheet (annual, 2022-12-31) — Retained Earnings: 5795217.00
JCE income_statement (annual, 2022-12-31) — Selling General And Administration: 208234.00
JCE balance_sheet (annual, 2022-12-31) — Share Issued: 16072627.00
JCE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 193568292.00
JCE balance_sheet (annual, 2022-12-31) — Tangible Book Value: 193568292.00
JCE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
JCE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
JCE balance_sheet (annual, 2022-12-31) — Total Assets: 194543933.00
JCE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 193568292.00
JCE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 975641.00
JCE income_statement (annual, 2023-12-31) — +Operating Expense: 218945.00
JCE income_statement (annual, 2023-12-31) — +Total Revenue: 40758589.00
JCE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 168468420.00
JCE balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 352017.00
JCE income_statement (annual, 2023-12-31) — Basic Average Shares: 16087160.00
JCE income_statement (annual, 2023-12-31) — Basic EPS: 2.52
JCE balance_sheet (annual, 2023-12-31) — Capital Stock: 160842.00
JCE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 0.00
JCE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 0.00
JCE balance_sheet (annual, 2023-12-31) — Cash Financial: 0.00
JCE balance_sheet (annual, 2023-12-31) — Common Stock: 160842.00
JCE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 213669234.00
JCE balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 514200.00
JCE income_statement (annual, 2023-12-31) — Diluted Average Shares: 16087160.00
JCE income_statement (annual, 2023-12-31) — Diluted EPS: 2.52
JCE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 40539644.00
JCE balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 213887823.00